Document:

The Alkaline Water Company Inc. - Exhibit 10.1 - Filed by newsfilecorp.com

TERMINATION OF STOCK OPTION AGREEMENT 

THIS AGREEMENT is entered into and made effective as of
_____________________________, 2016. 

BETWEEN: 

  
    
      
        THE ALKALINE WATER COMPANY INC., a company incorporated
          pursuant to the laws of the State of Nevada, with an office at 7730 E. Greenway
          Road, Suite 203, Scottsdale, Arizona, 85260 

        (the “Company”) 

      

    

  

AND: 

  
    
      
        <>, a <> 

        (the “Optionee”) 

      

    

  

WHEREAS: 

A.          
The Company granted <> stock options (the “Options”) to the
Optionee pursuant to the terms of a stock option agreement dated <> (the
“Stock Option Agreement”);

B.          
The Company proposes to grant <> stock options (the “New Options”)
to the Optionee pursuant to the terms of a stock option agreement dated
<>, 2017; 

C.          
In consideration for granting the New Options to the Optionee, the parties wish
to terminate the Stock Option Agreement and cancel the Options, with such
termination and cancellation to be effective immediately (collectively, the
“Termination”), on the terms and conditions set out herein.

NOW THEREFORE in consideration of the sum of ten dollars
($10.00), and for other good and valuable consideration the receipt and
sufficiency of which is hereby acknowledged, the Parties do hereby covenant and
agree as follows: 

	1. 	
      The Stock Option Agreement is hereby terminated as of
      <>, 2017, and is of no further force or effect. 

	  	
       

	2. 	
      The Options are hereby cancelled immediately. 

	  	
       

	3. 	
      The parties will execute and deliver all such further
      documents, do or cause to be done all such further acts and things, and
      give all such further assurances as may be necessary to give full effect
      to the provisions and intent of this Agreement. 

	  	
       

	4. 	
      There are no representations, warranties, collateral
      agreements, or conditions with respect to the subject matter of this
      Agreement except as herein specified. 

	  	
       

	5. 	
      This Agreement will enure to the benefit of and be
      binding upon the Parties and their respective heirs, executors,
      administrators, successors, and assigns. 

- 2 - 

	6. 	
      This Agreement may be executed in counterpart and such
      counterparts together will constitute a single instrument. Delivery of an
      executed counterpart of this Agreement by electronic means, including by
      facsimile transmission or by electronic delivery in portable document
      format (“.pdf”), will be equally effective as delivery of a manually
      executed counterpart hereof. The Parties acknowledge and agree that in any
      legal proceedings between them respecting or in any way relating to this
      Agreement, each waives the right to raise any defense based on the
      execution hereof in counterparts or the delivery of such executed
      counterparts by electronic means.

IN WITNESS WHEREOF the Parties have executed this Agreement as
of the date first written above. 

THE ALKALINE WATER COMPANY INC. 

	Per:            _____________________________________	  	  
	               
         Authorized Signatory 	  	  
	  	  	  
	SIGNED by <> in the presence of: 	) 	  
	  	) 	  
	  	) 	  
	Signature of Witness 	) 	  
	  	) 	  
	  	) 	  
	Name of Witness 	) 	 
    
	  	) 	<> 
	  	) 	  
	Address of Witness 	) 	  
	  	) 	  
	  	) 	  
	Address of Witness 	) 	  
	  	) 	  
	  	) 	  
	Occupation of Witness 	) 	  
	  	) 	  
	  	  	  
	OR 	  	  
	  	  	  
	<> 	  	  
	  	  	  
	  	  	  
	Per:            _____________________________________	  	  
	               
         Authorized SignatoryExhibit

	
										
	AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
	1. CONTRACT ID CODE
N/A
	PAGE   OF   PAGES

	1
	2

	2. AMENDMENT/MODIFICATION NO.
Modification 0012
	3. EFFECTIVE DATE
See Block 16 C
	4. REQUISITION/PURCHASE REQ. NO.
N/A
	5. PROJECT NO. (If applicable)
N/A

	6. ISSUED BY   CODE
	N/A
	7. ADMINISTERED BY (If other than Item 6)   CODE
	N/A

	HHS/OS/ASPR/AMCG 
330 Independence Avenue, SW. 
Room G640 
Washington, DC 20201
	 

	8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)
SIGA TECHNOLOGIES, INC.
35 E 62nd Street
New York, NY 10065
	(X)
	9A. AMENDMENT OF SOLICITATION NO.

	 

	9B. DATED (SEE ITEM 11)

	X
	10A. MODIFICATION OF CONTRACT/ORDER NO.
HHSO100201100001C

	10B. DATED (SEE ITEM 13)
05/13/2011

	CODE  N/A
	FACILITY CODE  N/A

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

~ The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers ~ is extended, ~ is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:  (a) By completing items 8 and 15, and returning ___________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment your desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)
2016 1992016.25103 -- Obligation amount: $4,813,378.00

13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS, IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
	
		
	()
	A.   THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

	 

	 
	B.   THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

	X
	C.   THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
FAR 52 243-2 – Changes – Cost Reimbursement and FAR 1 605-1 – Mutual Agreement of the Parties

	 
	D.   OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor [] is not, [ X] is required to sign this document and return   1   copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

PURPOSE:    This modification is to add additional funding under CLIN 0007 and update designated COR and Alternate COR.

FUNDS ALLOTED PRIOR TO MOD #12    $465,501,091.00
FUNDS ALLOTTED WITH MOD #12    $    4,813,378.00
TOTAL FUNDS ALLOTED TO DATE    $470,314,469.00 (Changed)
EXPIRATION DATE    September 24, 2020 (Unchanged)
CONTRACT FUNDED THROUGH    September 24, 2020 (Unchanged)

Total contract value is changed from Not To Exceed $588,234,077.21 to Not To Exceed $593,047,455.21

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
	
				
	15A. NAME AND TITLE OF SIGNER (Type or print)
 
Dennis E. Hruby            CSO
	16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
 
Linda D. Luczak, Contracting Officer

	15B. CONTRACTOR/OFFEROR

 /s/ Dennis E. Hruby
(Signature of person authorized to sign)
	15C. DATE SIGNED
22 Apr 2016
	16B. UNITED STATES OF AMERICA

  /s/ Linda D. Luczak
(Signature of Contracting Officer)
	16C. DATE SIGNED
4/22/16

NSN 7540-01-152-8070    OMB No 0990—0115    STANDARD FORM 30  (REV. 10-83) 

	
			
	Contract No.
HHSO100201100001C
Modification No.0012
	Continuation Sheet
Block 14
	Page 2 of 2

		
	1)
	The following revision is made to CLIN 0007 under this modification:

CLIN 0007 is revised from CPFF $42,031,228.44 (Est Cost: $39,652,102.19 & Fee $2,379,126.25) to CPFF $46,844.606.44 (Est. Cost: $44,193,024.83 & Fee $2,651,581.61), a total increase of $4,813,378 (Est. Cost: $4,540,922.64 & Fee $272,455.36). The amount of this increase to CLIN 0007 ($4,813,378) is being obligated under this modification.
The bid schedule table (under Section B) for CLIN 0007 is revised to read as follows:
	
						
	CLIN#
	Cost Type
	Supply or Service
	Estimated Cost
	Fee
	Total CPFF

	7
	CPFF
	Supportive Studies (Clinical/Non-Clinical) to include, but not limited to stability, non-clinical, and clinical studies as described in Sections C.2,and C.4)
	$44,193,024.83
	$2,651,581.61
	$46,844,606.44

		
	2)
	Update SECTION G, Article G.2. as follows and replace the designated COR and Alternate COR:

ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR) 
The following Contracting Officer's Representative (COR) will represent the Government for the purpose of this contract:
	
		
	Andrew [Drew] Albright
	– Primary COR

	Chia-Wei Tsai, PhD
	– Alternate COR

As delegated by the Contracting Officer, the COR is responsible for: (1) monitoring the Contractor's technical progress, including the surveillance and assessment of performance and recommending to the Contracting Officer changes in requirements; (2) assisting the contracting Officer in interpreting the statement of work and any other technical performance requirements; (3) performing technical evaluation as required ; (4) performing technical inspections and acceptances required by this contract; and (5) assisting in the resolution of technical problems encountered during performance.
All other terms and conditions of contract HHS0100201100001C remain unchanged.
END OF MODIFICATION 0012 TO HHS0100201100001C

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]